Performance of a multi-biomarker class, multi-cancer early detection (MCED) blood test in a prospectively collected cohort.
BACKGROUND Multi-biomarker blood tests have the potential to detect a broad range of cancer types and stages. Herein, we assessed the performance of a methylation and protein (MP) classifier using samples from a large, multi-center, prospectively collected case-control study. As part of the assay development process, w...